JMJD1C forms condensate to facilitate a RUNX1-dependent gene expression program shared by multiple types of AML cells
Year: 2024
Type: article
Abstract: JMJD1C (Jumonji Domain Containing 1C), a member of the lysine demethylase 3 (KDM3) family, is universally required for the survival of several types of acute myeloid leukemia (AML) cells with different genetic mutations, representing a therapeutic opportunity with broad application. Yet how JMJD1C regulates the leukemic programs of various AML cells is largely unexplored. Here we show that JMJD1C interacts with the master hematopoietic transcription factor RUNX1, which thereby recruits JMJD1C to the genome to facilitate a RUNX1-driven transcriptional program that supports leukemic cell survival. The underlying mechanism hinges on the long N-terminal disordered region of JMJD1C, which harbors two inseparable abilities: condensate formation and direct interaction with RUNX1. This dual capability of JMJD1C may influence enhancer-promoter contacts crucial for the expression of key leukemic genes regulated by RUNX1. Our findings demonstrate a previously unappreciated role for the non-catalytic function of JMJD1C in transcriptional regulation, underlying a mechanism shared by different types of leukemias.
Source: Protein & Cell
Authors: Qian Chen, Saisai Wang, Juqing Zhang, Min Xie, Bin Lu, Jie He, Zhuoran Zhen, Jing Li, Jiajun Zhu, Rong Li, Pilong Li, Haifeng Wang, Christopher R Vakoc, Robert G Roeder, Mo Chen
Institutions: State Key Laboratory of Molecular Oncology, Tsinghua University, Center for Life Sciences, Cold Spring Harbor Laboratory, Second Military Medical University, Changhai Hospital, Peking University, State Key Laboratory of Membrane Biology, Rockefeller University, Shanxi Medical University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,800
OpenAlex ID: W4403767720
